Micropos Medical is pleased to announce a state of the art electromagnetic tumor tracking solution for Varian users
Micropos is a medical device company with technologies for enhanced radiotherapy of cancer. Its product, RayPilot®, is an electromagnetic positioning system that works with existing linacs in order to enable non-ionizing, objective and real time prostate tracking.
Micropos is releasing a unique gating solution that is now qualified and compatible for use with Varian’s Clinac® iX linear accelerators and Trilogy® systems.
The RayPilot® consists of mainly three parts: a transmitter that is implanted in the prostate, a sensor plate that is placed directly on any existing couch top and a computer with software. Its function is similar to a GPS system by means that a target should be located in a given coordinate system. RayPilot initially gives information about Patient identification and where to position the couch in the set-up situation. When the treatment is delivered, RayPilot continuously registers the position of the tumor 30 times a second and gives a warning if the operator-defined margins are exceeded. All motion data is recorded and stored in a patient related database and can easily be accessed for further visual analyses or exported as Excel-files.
A connection between RayPilot SW via the Varian MMI interface enables patient synchronization and confirmation, objective set-up coordinates to be sent to Varian 4D Integrated Treatment Console (4DITC) for auto couch set-up, gating and repositioning of the couch if the position of the tumor stays out of tolerance.
The RayPilot System is CE-certified for prostate cancer use and can be used together with standard external radiotherapy or in combination with brachytherapy, boost or hypofractional treatment. In a near future RayPilot is expected to have a solution also for other treatment areas such as children, liver, gynecological and breast treatment. RayPilot’s upcoming combination of tracking and in-situ dosimetry, both in real time, will be clinically evaluated at the cancer center CGFL in Dijon, France during 2014.
– We are happy to offer our customers a solution that works together with their existing equipment and our intention is to additionally expand the RayPilot product portfolio with different versions for invasive, cavity and surface use says Tomas Gustafsson, CEO at Micropos Medical.
For further information contact:
Tomas Gustafsson, CEO, Micropos Medical AB (publ), +46-31-772 80 99, www.micropos.se
About Micropos Medical AB (publ):
Micropos Medical AB (www.micropos.se) is a Swedish company that has developed the RayPilot® system, which is an electromagnetic positioning and real time tracking system for a fast and objective set-up and for continuous positioning during radiotherapy. A precise and safe localization of the tumor can dramatically improve the outcome of the treatment, particularly for hypofractionated protocols. The RayPilot® system consists mainly of three parts; one transmitter that is placed close by the tumor, a receiving system that is placed directly on the treatment couchtop and software that continuously shows the precise tumor location, and hence where to focus the linac beam. During 2014 Micropos will release an upcoming RayPilot® transmitter for positioning, in-situ dosimetry and automatic patient identification. RayPilot® is CE certified for prostate use. Follow us on Facebook, http://www.facebook.com/MicroposMedical or follow press releases about the company on www.mynewsdesk.se search for Micropos and subscribe. The Micropos share is traded under the stock ticker MPOS.